BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 715,900 shares, a growth of 205.8% from the February 13th total of 234,100 shares. Currently, 14.3% of the shares of the company are sold short. Based on an average daily volume of 390,000 shares, the short-interest ratio is currently 1.8 days.

Institutional Trading of BioRestorative Therapies

An institutional investor recently bought a new position in BioRestorative Therapies stock. Citadel Advisors LLC purchased a new position in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTX) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned approximately 0.31% of BioRestorative Therapies at the end of the most recent quarter. 69.38% of the stock is currently owned by hedge funds and other institutional investors.

BioRestorative Therapies Stock Up 1.3 %

BioRestorative Therapies stock opened at $1.62 on Friday. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The firm has a market capitalization of $11.21 million, a price-to-earnings ratio of -1.06 and a beta of 64.37. The firm has a 50-day moving average price of $1.96 and a two-hundred day moving average price of $1.71.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.